US 10519224
Treating headache comprising administering an antibody to calcitonin gene-related peptide
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10519224 (Treating headache comprising administering an antibody to calcitonin gene-related peptide) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61P, A61P25/04